Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03507231 · ClinicalTrials.gov registry record · NA
Non-integrated Costs Increase Effectiveness of Incentives
A NA study of Control - No Incentive for Flu Vaccine and Direct Incentive, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 12,531
- Enrollment target
- 1
- Study location
NCT03507231 is a NA study of Control - No Incentive for Flu Vaccine and Direct Incentive that has completed, run by Carnegie Mellon University. The registered enrollment target is 12,531 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03507231, a NA study of Control - No Incentive for Flu Vaccine and Direct Incentive, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,531 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will test the hypothesis that the control (no incentive) condition will have the lowest vaccination rate, the main task condition will have a significantly higher vaccination rate while the indirect condition will have the highest vaccination rate. Participants will be randomly assigned to one of the three message conditions and their vaccination records obtained from the university Occupational Health Department.
Conditions Studied
Interventions
- BEHAVIORAL Email Message
- BEHAVIORAL Incentive for Vaccination
- BEHAVIORAL Incentive for completing a short survey
Study Locations (1)
New Jersey
- Rutgers University - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,531 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2018-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03507231
The ClinicalTrials.gov registry entry for NCT03507231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12,531 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carnegie Mellon University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Control - No Incentive for Flu Vaccine appearing as the primary indexed condition, and to 3 interventions - of which Email Message is the first listed.
NCT03507231 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03507231 about?
NCT03507231 is a clinical study titled "Non-integrated Costs Increase Effectiveness of Incentives". The investigators will test the hypothesis that the control (no incentive) condition will have the lowest vaccination rate, the main task condition will have a significantly higher vaccination rate while the indirect condition will have the highest vaccination rate. Participants will be randomly as...
What is the current status of trial NCT03507231?
This trial is currently completed. It is a NA study. The enrollment target is 12,531 participants. The study started on 2017-09-20. Estimated completion is 2018-01-20.
What conditions does trial NCT03507231 study?
This clinical trial studies the following conditions: Control - No Incentive for Flu Vaccine, Direct Incentive, Indirect Incentive.
What interventions are being tested in trial NCT03507231?
The interventions under investigation include: Email Message (BEHAVIORAL), Incentive for Vaccination (BEHAVIORAL), Incentive for completing a short survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT03507231?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03507231 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.